![Jennifer Low](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jennifer Low
Corporate Officer/Principal chez
23andMe, Inc.
Profil
Jennifer Low currently works at 23andMe, Inc., as Head-Therapeutics Development from 2018.
Dr. Low also formerly worked at Genentech, Inc., as Senior Group Medical Director-Product Development from 2006 to 2014, Roche Holding AG, as Member, 23andMe Holding Co., as Head-Therapeutics Development, National Cancer Institute, as Senior Investigator, and Loxo Oncology, Inc., as Chief Medical Officer, EVP-Research & Development from 2014 to 2016.
Dr. Low received her graduate degree from Duke University, undergraduate degree from California Institute of Technology, and doctorate degree from Georgetown University.
Postes actifs de Jennifer Low
| Sociétés | Poste | Début |
|---|---|---|
23andMe, Inc.
 23andMe, Inc. Medical SpecialtiesHealth Technology Develops DNA analysis test kits | Corporate Officer/Principal | 01/01/2018 |
Anciens postes connus de Jennifer Low
| Sociétés | Poste | Fin |
|---|---|---|
| CHROME HOLDING CO. | Corporate Officer/Principal | 01/01/2025 |
| LOXO ONCOLOGY INC | Directeur Technique/Scientifique/R&D | 01/01/2016 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/01/2014 |
| ROCHE HOLDING AG | Corporate Officer/Principal | - |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Corporate Officer/Principal | - |
Formation de Jennifer Low
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
83
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Georgetown University
 Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
23andMe, Inc.
23andMe, Inc. Medical SpecialtiesHealth Technology Develops DNA analysis test kits | Health Technology |
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicine for cancer treatment | Health Technology |
23andMe Holding Co.
 23andMe Holding Co. BiotechnologyHealth Technology Operates as a genetic testing company | Health Technology |
